DermaSensor announced today that the FDA cleared its real-time, non-invasive, AI-powered skin cancer evaluation system. Miami-based DermaSensor develops a handheld device that uses ESS, a form of optical spectroscopy. It takes noninvasive samples of tissue, capturing cellular-level information. The technology uses hundreds of wavelengths of light in a manner similar to how sonar uses sound. […]
dermasensor
DermaSensor reports positive results for skin cancer detection device across multiple skin tones
DermaSensor today announced promising results from a sub-analysis study focusing on skin cancer detection across different skin tones. The sub-analysis came from the company’s DERM-SUCCESS study, which previously demonstrated positive results. It focused on the company’s handheld elastic scattering spectroscopy (ESS) device performance across Fitzpatrick skin types. This skin tone scale classifies skin coloring and […]
Data supports DermaSensor skin cancer detection device
DermaSensor announced clinical data validating its handheld, non-invasive device for assisting in the detection of skin cancer. In collaboration with Mayo Clinic and the University of Connecticut School of Medicine, the company presented two studies. One demonstrated the standalone performance of DermaSensor’s novel elastic scattering spectroscopy (ESS) device. The other evaluated the impact of the […]
22 MedTech Innovator all-stars will pitch at DeviceTalks Boston
Nearly two dozen MedTech Innovator portfolio startups will pitch their technology to medtech industry innovators, executives and engineers at DeviceTalks Boston on May 10-11. The MedTech Innovator accelerator program picked the 22 all-stars from hundreds of applicants. The all-stars who will be featured over the two-day event at the Boston Convention and Exhibition Center are: […]
Studies back skin cancer detection device from DermaSensor
DermaSensor today presented data from two clinical studies supporting its non-invasive device for evaluating suspicious skin lesions. Miami, Florida-based DermaSensor’s handheld device uses a form of optical spectroscopy called elastic scattering spectroscopy (ESS). It takes noninvasive samples of tissue, capturing cellular-level information. The technology uses hundreds of wavelengths of light in a manner similar to […]
DermaSensor appoints trio of new executives
Skin cancer detection technology developer DermaSensor announced that it appointed three new members to its leadership team. Miami-based DermaSensor named Larry Anderson as its new chief commercial officer. Dr. Vivien Nguyen also joins as director of medical affairs, while the company promoted Ryan Freiden to COO. Anderson previously served as VP of sales for Acessa […]
How DermaSensor aims to expand access to accurate skin cancer detection
The company’s innovative DermaSensor device could save lives with early skin cancer detection capabilities. With tens of thousands of deaths each year in the U.S. attributable to skin cancer, 99% of deaths from melanoma — the most deadly skin cancer — are avoidable if detected at an early stage, Cody Simmons says. That’s where DermaSensor […]
DermaSensor raises $10M as it braces for U.S. launch
DermaSensor announced today that it raised an additional $10 million as it prepares for a commercial launch in the U.S. Miami, Florida-based DermaSensor’s $10 million fundraising accompanies news that the company met all primary endpoints for two FDA pivotal studies, setting it up to potentially offer the only FDA-cleared, automated skin cancer detection tool on […]
DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event
DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for cancer risk — is the winner of the MedTech Innovator Mid-Stage Companies Pitch Event. The Miami-based mid-stage company beat out 1,000 applicants, more than 20 of which competed on-site May 10–11, 2022 at DeviceTalks Boston. DermaSensor walked away with […]
DermaSensor raises $5.8m for handheld cancer detection device
DermaSensor has raised $5.8 million from 23 investors in an offering that began in November, according to a report filed with the SEC this month. The Florida-based company’s handheld device uses a light-emitting tip to evaluate potentially cancerous lesions on the surface of a patient’s skin. Using precision optics, the device can detect cellular pathological […]
